Wedbush assumed coverage of Passage Bio (PASG) with an Outperform rating and price target of $4, up from $3. Market sentiment may be different from the days when an extensive gene therapy pipeline of ...
Vinnie Mancuso is a Senior Editor at Collider, where he is in charge of all things related to the 2018 film 'Aquaman,' among other things. You can also find his pop culture opinions on Twitter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results